Demand for Minimally Invasive Technologies to Propel Implantable Drug Delivery Devices Market to USD 22.5 Billion by 2020

The global implantable drug delivery devices market is estimated to reach USD 22.5 Billion in 2020, growing at a CAGR of 6.0% from 2016 to 2020, according to a new market research report Implantable Drug Delivery Devices Market – Global Products, Technologies and Applications Analysis and Forecast 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Implantable Drug Delivery Devices Market – Global Products, Technologies and Applications Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/

Implantable drug delivery devices serve a variety of functions, from vascular stents that preserve blood flow to electro stimulation devices that regulate heart rhythm or block spurious signals in the brain to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees. Implantable devices allow site specific drug administration and allow for sustained release of a therapeutic agents, while the key material considerations include biocompatibility, stability and durability. The implantable drug delivery devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on device type (bio-absorbable stents, brachytherapy seeds, contraceptive devices, coronary drug eluting stents, drug infusion pumps, and intraocular devices), their underlying technologies (biodegradable and non-biodegradable), its applications (contraception, cardiovascular, oncology, ophthalmology, diabetes, chronic pain, etc.), and also forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

The global implantable drug delivery devices market is segmented as:

1. Device Type
1.1. Bio-Absorbable Stents
1.2. Brachytherapy Seeds
1.3. Contraceptive Devices
1.4. Coronary Drug Eluting Stents
1.5. Drug Infusion Pumps
1.6. Intraocular Devices

2. Technology
2.1. Biodegradable Drug Delivery Technology
2.2. Non-Biodegradable Drug Delivery Technology

3. Application
3.1. Birth Control (Contraception)
3.2. Cardiovascular
3.3. Oncology
3.4. Ophthalmology
3.5. Others (Diabetes, Chronic Pain)

1. Geography (Region, Country)
1.1. North America (U.S., Canada)
1.2. Latin America (Brazil, Mexico, Rest of LA)
1.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
1.4. Asia Pacific (Japan, China, India, Rest of APAC)
1.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories
4.2. Allergan, Inc.
4.3. Bausch & Lomb Inc.
4.4. Bayer Healthcare
4.5. Boston Scientific Corporation
4.6. Medtronic Inc.
4.7. Merck
4.8. Nucletron
4.9. Psivida Corporation

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.